Key result
The Defender 9001 dual chamber pacemaker defibrillator correctly diagnosed all 122 VT/VF episodes and 51 of 53 supraventricular tachyarrhythmias, offering improved diagnostic specificity.
Why the study?
Does a dual chamber pacemaker defibrillator accurately diagnose tachycardia episodes compared to physician diagnosis in patients requiring an ICD?
Observational (n=18)
Yes
Does a dual chamber pacemaker defibrillator accurately diagnose tachycardia episodes compared to physician diagnosis in patients requiring an ICD?
A dual chamber pacemaker defibrillator demonstrated high diagnostic accuracy for tachyarrhythmias, offering improved specificity without loss of sensitivity.
Answers are grounded in this paper and cite their sources.
May enhance SVT discrimination in dual-chamber ICDs; leaves open whether this reduces inappropriate shocks in trials.
The lack of specificity of VT detection is a significant shortcoming of current ICDs. In a French multicenter study, 18 patients underwent implantation of the Defender 9001 (ELA Medical), an ICD utilizing dual chamber pacing and arrhythmia detection. Over a mean follow-up period of 7.1 +/- 4.5 months, 176 tachycardia episodes recorded in the device memory were analyzed, and physician diagnosis was compared with that by the device. All 122 VT/VF episodes were correctly diagnosed, as were 51 of 53 supraventricular tachyarrhythmias. Two episodes of AF with rapid regular ventricular rates were treated as VT, and a third episode, treated as VT, could not be diagnosed with certainty. A dual chamber pacemaker defibrillator offers improved diagnostic specificity without loss of sensitivity, in addition to the hemodynamic benefit of dual chamber pacing.
No takes yet. Share an insight, caveat, or question.
Lavergne et al. (1997) conducted an observational in Ventricular tachyarrhythmias (n=18). Defender 9001 dual chamber pacemaker defibrillator was evaluated on Correct diagnosis of tachycardia episodes (device vs physician diagnosis). The Defender 9001 dual chamber pacemaker defibrillator correctly diagnosed all 122 VT/VF episodes and 51 of 53 supraventricular tachyarrhythmias, offering improved diagnostic specificity.
Synapse has enriched 10 related papers. Consider them for comparative context: